Riverside Partners Invests in Stinger Medical
Jan 09, 2013 (Close-Up Media via COMTEX) --
Riverside Partners announced that it has completed an investment in Stinger Medical, a provider of mobile clinical workstations and medical technologies.
According to a release, Riverside Partners' investment was completed in partnership with the Stinger management team and the Founder of the business.
Headquartered in Murfreesboro, Tennessee, Stinger Medical provides mobile medical workstations and related technologies for the acute care market. Stinger's team is dedicated to creating products that streamline workflow processes, reduce errors, enhance the quality of patient care and help providers comply with meaningful use guidelines. Stinger's proprietary Mobius Power solution and its fleet tracking technology, CAST, also enhance provider care to patients.
"Given the rapidly evolving dynamics of today's healthcare ecosystem, Stinger was looking for an investment partner not only to help us grow, but also to help us navigate the increasingly complex healthcare IT market. We believe that Riverside Partners' focus on technology investing as well as their deep expertise in healthcare makes them the perfect combination," said Gary Coonan, Founder and CEO of Stinger Medical. "We are already beginning to benefit from the healthcare operating resources that come with our partnership with Riverside Partners."
"Stinger Medical is clearly the innovation leader in the mobile clinical workstation industry and the company continues to develop advanced new technologies for this rapidly growing market. Stinger's products are pivotal in helping hospitals effectively deploy electronic health records and improve caregiver workflow and patient care," said Philip Borden, General Partner at Riverside Partners. "And Stinger's strong commitment to R&D makes us even more excited about the future of technology integration with providers."
Riverside Partners is a middle market private equity firm currently investing Riverside Partners Fund V, L.P.
((Comments on this story may be sent to firstname.lastname@example.org))
[ Back To IBM News 's Homepage ]